Virus News and Research

Latest Virus News and Research

Debiopharm recognised with European Biopharmaceuticals company of the year award

Debiopharm recognised with European Biopharmaceuticals company of the year award

SPARTAC study examines ways to limit immune system damage in HIV infection

SPARTAC study examines ways to limit immune system damage in HIV infection

Not all HIV viruses are bad for the immune system

Not all HIV viruses are bad for the immune system

Bill & Melinda Gates Foundation awards $6M grant to NanoBio to develop intranasal vaccine for RSV

Bill & Melinda Gates Foundation awards $6M grant to NanoBio to develop intranasal vaccine for RSV

PhRMA reports 100 new medicines and vaccines in development for HIV/AIDS

PhRMA reports 100 new medicines and vaccines in development for HIV/AIDS

Research on patients' immune system may lead to new diagnostic tool for HIV treatment

Research on patients' immune system may lead to new diagnostic tool for HIV treatment

Opinions: Obama's Global Fund pledge; harm reduction in Iran; HIV prevention; African development

Opinions: Obama's Global Fund pledge; harm reduction in Iran; HIV prevention; African development

HIV testing rates rise among Americans

HIV testing rates rise among Americans

Canadians at increased risk for flu complications not aware of all the facts

Canadians at increased risk for flu complications not aware of all the facts

Pharmasset commences combination study of PSI-7977 and PSI-938 nucleotide analogs in HCV

Pharmasset commences combination study of PSI-7977 and PSI-938 nucleotide analogs in HCV

Cytheris' combinational therapy demonstrates possible therapeutic strategy for PML

Cytheris' combinational therapy demonstrates possible therapeutic strategy for PML

GeoVax supports Bionor's Phase 2b trial of therapeutic HIV/AIDS vaccine

GeoVax supports Bionor's Phase 2b trial of therapeutic HIV/AIDS vaccine

University of Adelaide researcher leads collaboration for universal flu vaccine

University of Adelaide researcher leads collaboration for universal flu vaccine

NIAID scientists confirm antiviral activity of two lead compounds against HPV

NIAID scientists confirm antiviral activity of two lead compounds against HPV

Merck announces initial results from ISENTRESS Phase III study in HIV-1

Merck announces initial results from ISENTRESS Phase III study in HIV-1

USPTO awards Immunitor key patent for viral vaccine

USPTO awards Immunitor key patent for viral vaccine

Superantigens can disrupt immune system, can cause more illnesses

Superantigens can disrupt immune system, can cause more illnesses

Medicago, Genopole expand collaboration

Medicago, Genopole expand collaboration

Hepatitis C outbreak investigation continues

Hepatitis C outbreak investigation continues

How HIV kills CD4 T cells

How HIV kills CD4 T cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.